Sanders-Led Panel Exposes Big Pharma for 'Ripping Off' Americans With Publicly Funded Meds

Indonesia Berita Berita

Sanders-Led Panel Exposes Big Pharma for 'Ripping Off' Americans With Publicly Funded Meds
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 commondreams
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

'It is unacceptable that half of new prescription drugs invented with the help of NIH scientists now cost more than $111,000,' said SenSanders, urging action by the Biden administration to cut prices.

;&#x201cEssential reading from @SenSanders @HELPCmteDems on US taxpayers' immense contributions through @NIH to the development of new treatments; despite this, median price is $111,000 & US taxpayers almost always pay more than other countries for these publicly-funded treatments.;&#x201dThe new report states that"U.S. taxpayers virtually always pay more than people in other countries for treatments that NIH scientists helped invent.

Tecartus and Yescarta, manufactured by Gilead Sciences to treat cancer, both cost $424,000 in the United States, while the price for Tecartus in Germany is $306,000 and Yescarta is $212,000 in Japan. "Congress provided nearly $54 billion for biomedical research across the U.S. government this year" and NIH alone has a $47.5 billion budget,"making it the largest biomedical research funder in the world," the report notes, stressing that"the federal government sets the stage for new medicines with its substantial investments."

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

commondreams /  🏆 530. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Sanders vows to oppose NIH nominee until Biden produces drug-pricing planSanders vows to oppose NIH nominee until Biden produces drug-pricing planSen. Bernie Sanders (I-Vt.), chair of the Senate health panel, is vowing to not move forward with President Biden’s nominee to lead the National Institutes of Health until he receives the administration’s “comprehensive” plan on lowering drug prices.
Baca lebih lajut »

NIH to intensify scrutiny of foreign grant recipients in wake of COVID origins debateNIH to intensify scrutiny of foreign grant recipients in wake of COVID origins debateResearchers speak out over US biomedical agency’s new funding policy.
Baca lebih lajut »

NIH working group calls for fewer—but better paid—postdocsPostdocs in U.S. biomedical research labs should be paid better, even if it means supporting fewer of them. That’s the preliminary position of a working group formed by the U.S. National Institutes of Health.
Baca lebih lajut »

Exclusive: MTG 'Dumbfounded' GOP Won't Call for Biden's ImpeachmentExclusive: MTG 'Dumbfounded' GOP Won't Call for Biden's Impeachment.RepMTG: “We have to impeach [Biden] in the House to show and prove to our voters that we’re willing to do these things, are willing to bring accountability. If we don’t do it, then why do they want to vote for us?”
Baca lebih lajut »

Donald Trump indicted: Trump says Biden bribe claims planned for same day as chargesDonald Trump indicted: Trump says Biden bribe claims planned for same day as chargesFormer President Donald Trump complained on Saturday about his federal indictment taking place the same day that House Republicans secured access to a FBI document alleging President Joe Biden's involvement in a 'criminal bribery scheme.'
Baca lebih lajut »

Biden lauds pride event-goers as most courageous he's seen recently, days after military addressBiden lauds pride event-goers as most courageous he's seen recently, days after military addressBiden said that he saw more courage at the White House LGBT+ pride event than 'in the recent past' — comments made ten days after he visited the Air Force.
Baca lebih lajut »



Render Time: 2025-02-28 01:29:17